26 October 2017 EMA/716519/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance(s): frovatriptan

Procedure No.: PSUSA/00001484/201703

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country)

Allegro® 2,5 mg Filmtabletten AURADOL 2,5 mg compresse rivestite con film AURADOL 2,5 mg compresse rivestite con film AURADOL 2,5 mg compresse rivestite con film DORLISE 2,5 mg comprimidos revestidos por película DORLISE 2,5 mg comprimidos revestidos por película DORLISE 2,5 mg comprimidos revestidos por película DORLISE 2,5 mg comprimidos revestidos por película DORLISE 2,5 mg comprimidos revestidos por película DORLISE 2,5 mg comprimidos revestidos por película DORLISE 2,5 mg comprimidos revestidos por película EUMITAN 2,5 mg – Filmtabletten Forvey 2,5 mg comprimidos recubiertos con película FROMEN 2,5 mg, potahované tablety FROMIREX 2,5 mg filmomhulde tabletten FROTAN 2,5 mg filmsko obložene tablete FROTAN 2,5 mg filmsko obložene tablete FROTAN 2,5 mg filmsko obložene tablete FROTAN 2,5 mg filmsko obložene tablete FROTAN 2,5 mg filmsko

MRP/DCP Authorisation number

National Authorisation Number

FR/H/0199/001

52682.00.00

FR/H/0199/001

035673021

FR/H/0199/001

035673033

FR/H/0199/001

035673019

FR/H/0199/001

3901188

FR/H/0199/001

3900685

FR/H/0199/001

3900784

FR/H/0199/001

3900883

FR/H/0199/001

4908588

FR/H/0199/001

3901089

FR/H/0199/001

3900982

FR/H/0195/001

1-24486

FR/H/0195/001

65.009

FR/H/0199/001

33/030/05-C

FR/H/0199/001

RVG 27212

FR/H/0199/001

H/05/00660/005

FR/H/0199/001

H/05/00660/004

FR/H/0199/001

H/05/00660/006

FR/H/0199/001 FR/H/0199/001

H/05/00660/007 H/05/00660/001

List of nationally authorised medicinal products EMA/716519/2017

MAH of product in the member state

BERLIN-CHEMIE AG ISTITUTO LUSO FARMACO D'ITALIA S.P.A. ISTITUTO LUSO FARMACO D'ITALIA S.P.A. ISTITUTO LUSO FARMACO D'ITALIA S.P.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL

Member State where product is authorised

DE IT IT IT PT PT PT PT PT PT PT AT ES CZ NL SI SI SI SI SI

Page 2/7

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

FR/H/0199/001

H/05/00660/002

FR/H/0199/001

H/05/00660/003

Frovalon 2,5 mg filmtabletta

FR/H/0199/001

OGYI-T-9671/06

Frovalon 2,5 mg filmtabletta

FR/H/0199/001

OGYI-T-9671/05

Frovalon 2,5 mg filmtabletta

FR/H/0199/001

OGYI-T-9671/02

Frovalon 2,5 mg filmtabletta

FR/H/0199/001

OGYI-T-9671/01

Frovalon 2,5 mg filmtabletta

FR/H/0199/001

OGYI-T-9671/03

Frovalon 2,5 mg filmtabletta

FR/H/0199/001

OGYI-T-9671/04

Frovalon 2,5 mg filmtabletta Frovamen 2,5 mg filmom obalené tablety FROVAMIG 2,5 mg Filmtabletten FROVATEX 2,5 mg comprimés pelliculés FROVATEX 2,5 mg comprimés pelliculés FROVATEX 2,5 mg comprimés pelliculés FROVATEX 2,5 mg filmomhulde tabletten FROVATEX 2,5 mg filmomhulde tabletten

FR/H/0199/001

OGYI-T-9671/07

FR/H/0199/001

07/0035/05-S

FR/H/0199/001

1-24487

FR/H/0199/001

BE240344

FR/H/0199/001

BE240353

FR/H/0199/001

0951/09020212

FR/H/0199/001

BE240344

FR/H/0199/001

BE240353

FROVATEX 2,5 mg Filmtabletten

FR/H/0199/001

BE240344

FROVATEX 2,5 mg Filmtabletten

FR/H/0199/001

BE240353

obložene tablete FROTAN 2,5 mg filmsko obložene tablete FROTAN 2,5 mg filmsko obložene tablete

List of nationally authorised medicinal products EMA/716519/2017

MAH of product in the member state

OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.

Member State where product is authorised

SI SI HU HU HU HU HU HU HU SK AT BE BE LU BE BE BE BE

Page 3/7

Product Name (in authorisation country)

FROVEX 2.5 mg film-coated tablets ISIMIG 2,5 mg, comprimé pelliculé ISIMIG 2,5 mg, comprimé pelliculé ISIMIG 2,5 mg, comprimé pelliculé ISIMIG 2,5 mg, comprimé pelliculé Migard 2,5 mg apvalkotās tabletes MIGARD 2,5 mg comprimés pelliculés MIGARD 2,5 mg comprimés pelliculés MIGARD 2,5 mg comprimés pelliculés MIGARD 2,5 mg comprimidos revestidos por película MIGARD 2,5 mg comprimidos revestidos por película MIGARD 2,5 mg comprimidos revestidos por película MIGARD 2,5 mg comprimidos revestidos por película MIGARD 2,5 mg comprimidos revestidos por película MIGARD 2,5 mg comprimidos revestidos por película MIGARD 2,5 mg comprimidos revestidos por película Migard 2,5 mg filmdragerad tablett MIGARD 2,5 mg filmdragerade tabletter Migard 2,5 mg filmom obalené

MRP/DCP Authorisation number

National Authorisation Number

FR/H/0199/001

PA 865/9/1

FR/H/0195/001

34009 355 617 5 6

FR/H/0195/001

34009 377 829 5 1

FR/H/0195/001

34009 355 616 9 5

FR/H/0195/001

34009 563 244 3 9

FR/H/0195/001

05-0053

FR/H/0195/001

BE239574

FR/H/0195/001

BE239565

FR/H/0195/001

0951/09020213

FR/H/0195/001

4908687

FR/H/0195/001

3900487

FR/H/0195/001

3900081

FR/H/0195/001

3900388

FR/H/0195/001

3900289

FR/H/0195/001

3900586

FR/H/0195/001

3900180

FR/H/0195/001

16913

FR/H/0195/001 FR/H/0195/001

17881 07/0034/05-S

List of nationally authorised medicinal products EMA/716519/2017

MAH of product in the member state

MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL

Member State where product is authorised

IE FR FR FR FR LV BE BE LU PT PT PT PT PT PT PT FI SE SK

Page 4/7

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

FR/H/0195/001

BE239565

FR/H/0195/001

BE239574

FR/H/0195/001

RVG 27211

FR/H/0195/001

5363-I-775/09

FR/H/0195/001

5363-I-777/09

FR/H/0195/001

5363-I-776/09

Migard 2,5 mg filmtabletta

FR/H/0195/001

OGYI-T-10078/02

Migard 2,5 mg filmtabletta

FR/H/0195/001

OGYI-T-10078/03

Migard 2,5 mg filmtabletta

FR/H/0195/001

OGYI-T-10078/06

Migard 2,5 mg filmtabletta

FR/H/0195/001

OGYI-T-10078/01

Migard 2,5 mg filmtabletta

FR/H/0195/001

OGYI-T-10078/04

Migard 2,5 mg filmtabletta

FR/H/0195/001

OGYI-T-10078/05

Migard 2,5 mg filmtabletta

FR/H/0195/001

OGYI-T-10078/07

MIGARD 2,5 mg Filmtabletten

FR/H/0195/001

BE239574

MIGARD 2,5 mg Filmtabletten MIGARD 2,5 mg filmuhúðaðar töflur MIGARD 2,5 mg kalvopäällysteiset tabletit Migard 2,5 mg plėvele dengtos tabletės

FR/H/0195/001

BE239565

FR/H/0195/001

IS/1/04/060/01

FR/H/0195/001

16913

FR/H/0195/001

LT/1/05/0204/006

tablety MIGARD 2,5 mg filmomhulde tabletten MIGARD 2,5 mg filmomhulde tabletten MIGARD 2,5 mg filmomhulde tabletten MIGARD 2,5 mg filmsko obložene tablete MIGARD 2,5 mg filmsko obložene tablete MIGARD 2,5 mg filmsko obložene tablete

List of nationally authorised medicinal products EMA/716519/2017

MAH of product in the member state

OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.

Member State where product is authorised

BE BE NL SI SI SI HU HU HU HU HU HU HU BE BE IS FI LT

Page 5/7

Product Name (in authorisation country)

Migard 2,5 mg plėvele dengtos tabletės Migard 2,5 mg plėvele dengtos tabletės Migard 2,5 mg plėvele dengtos tabletės Migard 2,5 mg plėvele dengtos tabletės Migard 2,5 mg plėvele dengtos tabletės Migard 2,5 mg plėvele dengtos tabletės Migard 2,5 mg tabletki powlekane MIGARD 2,5 mg tabletter, filmdrasjerte Migard 2,5 mg, filmovertrukne tabletter MIGARD 2.5 mg film-coated tablets Migard, 2,5 mg õhukese polümeerikattega tabletid Migard® 2,5 mg Filmtabletten MIGRALIN® Επικαλυμμένο με λεπτό υμένιο δισκίο 2,5mg/TAB MIGUAR 2.5 mg film-coated tablets PITUNAL® Επικαλυµµένο µε λεπτό υµένιο δισκίο 2,5mg/TAB RILAMIG 2,5 mg compresse rivestite con film RILAMIG 2,5 mg compresse rivestite con film RILAMIG 2,5 mg compresse rivestite con film TIGREAT 2,5 mg filmuhúðaðar

MRP/DCP Authorisation number

National Authorisation Number

FR/H/0195/001

LT/1/05/0204/002

FR/H/0195/001

LT/1/05/0204/004

FR/H/0195/001

LT/1/05/0204/001

FR/H/0195/001

LT/1/05/0204/003

FR/H/0195/001

LT/1/05/0204/007

FR/H/0195/001

LT/1/05/0204/005

FR/H/0195/001

11408

FR/H/0195/001

04-2946

FR/H/0195/001

33100

FR/H/0195/001

PL 16239/0017

FR/H/0195/001

463805

FR/H/0195/001

52681.00.00

FR/H/0199/001

15931

FR/H/0195/001

PA 865/8/1

FR/H/0195/001

15932

FR/H/0195/001

035674023

FR/H/0195/001

035674011

FR/H/0195/001 FR/H/0199/001

035674035 IS/1/04/059/01

List of nationally authorised medicinal products EMA/716519/2017

MAH of product in the member state

MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL

Member State where product is authorised

LT LT LT LT LT LT PL NO DK UK EE DE GR IE GR IT IT IT IS

Page 6/7

Product Name (in authorisation country)

töflur TIGREAT 2,5 mg, comprimé pelliculé TIGREAT 2,5 mg, comprimé pelliculé TIGREAT 2,5 mg, comprimé pelliculé TIGREAT 2,5 mg, comprimé pelliculé Релиева 2,5 mg филмирани таблетки

MRP/DCP Authorisation number

National Authorisation Number

FR/H/0199/001

34009 361 564 7 0

FR/H/0199/001

34009 357 554 0 7

FR/H/0199/001

34009 357 553 4 6

FR/H/0199/001

34009 357 555 7 5

not available

20040485

List of nationally authorised medicinal products EMA/716519/2017

MAH of product in the member state

OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.

Member State where product is authorised

FR FR FR FR BG

Page 7/7

PSUSA/00001484/201703 - European Medicines Agency - Europa EU

Oct 26, 2017 - λεπτό υμένιο δισκίο 2,5mg/TAB FR/H/0199/001. 15931. MENARINI INTERNATIONAL. OPERATIONS LUXEMBOURG S.A.. GR. MIGUAR 2.5 mg ...

192KB Sizes 11 Downloads 143 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...